134057-95-7

Basic information

• Product Name: 3-(4-BROMO-2-FLUORO-PHENYL)-PROPIONIC ACID
• Synonyms: 3-(4-BROMO-2-FLUORO-PHENYL)-PROPIONIC ACID;3-(4-Bromo-2-fluorophenyl)propanoic acid
• CAS NO: 134057-95-7
• Molecular Formula: C₉H₈BrFO₂
• Molecular Weight: 247.0610232
• Product Categories: pharmaceutical
• Mol File: 134057-95-7.mol

Chemical Properties

• Boiling Point: 331.5±27.0 °C(Predicted)
• Appearance: /
• Density: 1.606±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 4.60±0.10(Predicted)
• CAS DataBase Reference: 3-(4-BROMO-2-FLUORO-PHENYL)-PROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-BROMO-2-FLUORO-PHENYL)-PROPIONIC ACID(134057-95-7)
• EPA Substance Registry System: 3-(4-BROMO-2-FLUORO-PHENYL)-PROPIONIC ACID(134057-95-7)

Safety Data

• Hazardous Substances Data: 134057-95-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
3-(4-BROMO-2-FLUORO-PHENYL)-PROPIONIC ACID is used as a reagent in chemical reactions for its potential anti-inflammatory and analgesic properties, contributing to the development of new drugs for pain management and inflammation-related conditions.
Used in Organic Synthesis:
In the field of organic synthesis, 3-(4-BROMO-2-FLUORO-PHENYL)-PROPIONIC ACID is utilized as a precursor in the synthesis of various pharmaceutical compounds, leveraging its unique chemical structure to create novel therapeutic agents.
Used in Drug Development:
3-(4-BROMO-2-FLUORO-PHENYL)-PROPIONIC ACID is employed in drug development as a key component in the formulation of new medications aimed at treating pain and inflammation, due to its demonstrated potential in these areas.

Upstream product

• 76283-09-5 4-bromo-2-fluorobenzyl bromide 
• 108-59-8 malonic acid dimethyl ester 
• 942282-43-1 (4-bromo-2-fluorophenyl)methyl Methanesulfonate 
• 188582-62-9 4-bromo-2-fluorobenzyl alcohol 

Downstream Products

• 881189-74-8 6-bromo-4-fluoro-2,3-dihydro-1H-inden-1-one 
• 134057-96-8 3-(4-Bromo-2-fluoro-phenyl)-propionaldehyde 
• 1057671-56-3 3-(4-Bromo-2-fluoro-phenyl)-propan-1-ol 

Relevant articles and documents

Potent Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold

With the discovery that serine hydroxymethyltransferase (SHMT) is a druggable target for antimalarials, the aim of this study was to design novel inhibitors of this key enzyme in the folate biosynthesis cycle. Herein, 19 novel spirocyclic ligands based on

Syntheses of tolrestat analogues containing additional substituents in the ring and their evaluation as aldose reductase inhibitors. Identification of potent, orally active 2-fluoro derivatives

A series of aldose reductase inhibitors were prepared which were analogues of the potent, orally active inhibitor tolrestat (1). These compounds (5, 7, 9, and 10) have an extra substituent on one of the unoccupied positions on the naphthalene ring of 1. P